Detalles de la búsqueda
1.
Inducing intravesical hyperthermia of the ex-vivo porcine bladder wall: radiofrequency-induction versus recirculation using a custom-made device.
Int J Hyperthermia
; 35(1): 323-329, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30303406
2.
Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.
Qual Life Res
; 27(1): 115-124, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28917029
3.
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry.
BMC Cancer
; 16: 364, 2016 06 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27286871
4.
Scaffold-based tissue engineering: Supercritical carbon dioxide as an alternative method for decellularization and sterilization of dense materials.
Acta Biomater
; 155: 323-332, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36423818
5.
Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.
Br J Cancer
; 106(5): 916-22, 2012 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-22333602
6.
Bone tumor-targeted delivery of theranostic 195mPt-bisphosphonate complexes promotes killing of metastatic tumor cells.
Mater Today Bio
; 9: 100088, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33490949
7.
Patient and Disease Characteristics are Important Determinants of Health-Related Quality of Life of Patients with Metastatic Renal Cell Carcinoma Results from a Population-Based Registry.
Value Health
; 17(7): A649, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27202337
8.
Curcumin as Treatment for Bladder Cancer: A Preclinical Study of Cyclodextrin-Curcumin Complex and BCG as Intravesical Treatment in an Orthotopic Bladder Cancer Rat Model.
Biomed Res Int
; 2018: 9634902, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29984253
9.
Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments.
PLoS One
; 12(5): e0177364, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28531203
10.
Bioinspired coupled helical coils for soft tissue engineering of tubular structures - Improved mechanical behavior of tubular collagen type I templates.
Acta Biomater
; 59: 234-242, 2017 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28666884
11.
A theranostic dental pulp capping agent with improved MRI and CT contrast and biological properties.
Acta Biomater
; 62: 340-351, 2017 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28842333
12.
Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib-Treated Cancer.
CPT Pharmacometrics Syst Pharmacol
; 6(9): 604-613, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28571114
13.
Complex cadherin expression in renal cell carcinoma.
Cancer Res
; 56(14): 3234-7, 1996 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-8764114
14.
The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes.
Cancer Res
; 59(21): 5554-9, 1999 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-10554034
15.
Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma.
Cancer Res
; 55(23 Suppl): 5864s-5867s, 1995 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-7493361
16.
Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapy.
Cancer Res
; 59(7): 1615-9, 1999 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-10197637
17.
Pretargeting of renal cell carcinoma: improved tumor targeting with a bivalent chelate.
Cancer Res
; 59(17): 4400-5, 1999 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-10485489
18.
Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250.
J Clin Oncol
; 11(4): 738-50, 1993 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-8478666
19.
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250.
J Clin Oncol
; 15(4): 1529-37, 1997 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-9193349
20.
Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma.
Clin Cancer Res
; 4(10): 2419-24, 1998 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-9796973